Wooridul Huebrain Limited (118000.KS)
KRW 316.0
(-1.25%)
KRW 316.0
(-1.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 213.88 Million KRW | -97.97% |
| 2022 | 10.55 Billion KRW | 5927.19% |
| 2021 | 175.07 Million KRW | -59.31% |
| 2020 | 430.23 Million KRW | 177.37% |
| 2019 | 155.11 Million KRW | 0.0% |
| 2018 | - KRW | 0.0% |
| 2017 | - KRW | 0.0% |
| 2016 | - KRW | 0.0% |
| 2015 | - KRW | 0.0% |
| 2014 | - KRW | 0.0% |
| 2013 | - KRW | 0.0% |
| 2012 | - KRW | 0.0% |
| 2011 | - KRW | -100.0% |
| 2010 | 28.52 Billion KRW | 0.0% |
| 2009 | - KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 46.31 Million KRW | 0.0% |
| 2024 Q2 | 290.5 Million KRW | 0.0% |
| 2023 Q2 | 277.5 Million KRW | -97.03% |
| 2023 Q1 | 9.33 Billion KRW | -11.51% |
| 2023 FY | 213.88 Million KRW | -97.97% |
| 2023 Q3 | 58.2 Million KRW | -79.03% |
| 2023 Q4 | 213.88 Million KRW | 267.47% |
| 2022 Q3 | 79.49 Million KRW | -16.82% |
| 2022 Q1 | 148.81 Million KRW | -15.0% |
| 2022 FY | 10.55 Billion KRW | 5927.19% |
| 2022 Q4 | 10.55 Billion KRW | 13174.56% |
| 2022 Q2 | 95.56 Million KRW | -35.79% |
| 2021 Q1 | 12.77 Billion KRW | 2870.27% |
| 2021 Q3 | 183.63 Million KRW | -98.56% |
| 2021 Q4 | 175.07 Million KRW | -4.66% |
| 2021 Q2 | 12.77 Billion KRW | 0.0% |
| 2021 FY | 175.07 Million KRW | -59.31% |
| 2020 Q2 | 461.56 Million KRW | 174.89% |
| 2020 Q4 | 430.23 Million KRW | 0.98% |
| 2020 FY | 430.23 Million KRW | 177.37% |
| 2020 Q1 | 167.9 Million KRW | 8.25% |
| 2020 Q3 | 426.04 Million KRW | -7.69% |
| 2019 Q1 | - KRW | 0.0% |
| 2019 Q2 | 168.19 Million KRW | 0.0% |
| 2019 FY | 155.11 Million KRW | 0.0% |
| 2019 Q3 | 161.92 Million KRW | -3.73% |
| 2019 Q4 | 155.11 Million KRW | -4.21% |
| 2018 Q4 | - KRW | 0.0% |
| 2018 Q3 | - KRW | 0.0% |
| 2018 Q2 | - KRW | 0.0% |
| 2018 FY | - KRW | 0.0% |
| 2018 Q1 | - KRW | 0.0% |
| 2017 Q1 | - KRW | 0.0% |
| 2017 Q4 | - KRW | 0.0% |
| 2017 FY | - KRW | 0.0% |
| 2017 Q2 | - KRW | 0.0% |
| 2017 Q3 | - KRW | 0.0% |
| 2016 Q2 | - KRW | 0.0% |
| 2016 FY | - KRW | 0.0% |
| 2016 Q4 | - KRW | 0.0% |
| 2016 Q3 | - KRW | 0.0% |
| 2016 Q1 | - KRW | 0.0% |
| 2015 FY | - KRW | 0.0% |
| 2015 Q3 | - KRW | 0.0% |
| 2015 Q2 | - KRW | 0.0% |
| 2015 Q1 | - KRW | 0.0% |
| 2015 Q4 | - KRW | 0.0% |
| 2014 Q4 | - KRW | -100.0% |
| 2014 FY | - KRW | 0.0% |
| 2014 Q3 | 4.97 Billion KRW | 0.13% |
| 2014 Q2 | 4.97 Billion KRW | 0.0% |
| 2014 Q1 | - KRW | 0.0% |
| 2013 FY | - KRW | 0.0% |
| 2013 Q4 | - KRW | 0.0% |
| 2012 Q2 | - KRW | 0.0% |
| 2012 Q3 | - KRW | 0.0% |
| 2012 Q4 | - KRW | 0.0% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q1 | - KRW | 0.0% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 Q3 | 32.33 Billion KRW | 87.47% |
| 2011 FY | - KRW | -100.0% |
| 2011 Q1 | 35.76 Billion KRW | 25.39% |
| 2011 Q2 | 17.25 Billion KRW | -51.77% |
| 2010 FY | 28.52 Billion KRW | 0.0% |
| 2010 Q3 | 9.43 Billion KRW | 0.0% |
| 2010 Q1 | - KRW | 0.0% |
| 2010 Q4 | 28.52 Billion KRW | 202.5% |
| 2010 Q2 | - KRW | 0.0% |
| 2009 FY | - KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Daewoong Co., Ltd. | 93.41 Billion KRW | 99.771% |
| PharmGen Science, Inc. | 532.33 Million KRW | 59.821% |